Showing 13 to 24 of 139 results
Donanemab Approved for Early-Stage Alzheimer's with Stricter Guidelines
Donanemab, a new Alzheimer's drug, received conditional approval in Europe, slowing disease progression by up to six months in early stages for patients with mild cognitive impairment and only one copy of the ApoE4 gene, but with risks of brain swelling and bleeding.
Donanemab Approved for Early-Stage Alzheimer's with Stricter Guidelines
Donanemab, a new Alzheimer's drug, received conditional approval in Europe, slowing disease progression by up to six months in early stages for patients with mild cognitive impairment and only one copy of the ApoE4 gene, but with risks of brain swelling and bleeding.
Progress
48% Bias Score
Four Pathways to Dementia Identified, Revolutionizing Diagnosis and Treatment
A new study published in The Lancet identified four distinct pathways to developing dementia—psychiatric conditions, brain dysfunction illnesses, mild cognitive impairments, and heart disease—in an analysis of over 24,000 patients, potentially revolutionizing diagnosis and treatment.
Four Pathways to Dementia Identified, Revolutionizing Diagnosis and Treatment
A new study published in The Lancet identified four distinct pathways to developing dementia—psychiatric conditions, brain dysfunction illnesses, mild cognitive impairments, and heart disease—in an analysis of over 24,000 patients, potentially revolutionizing diagnosis and treatment.
Progress
40% Bias Score
Four Distinct Autism Subtypes Discovered, Unlocking Targeted Treatments
A Princeton University and Simons Foundation study identified four distinct autism subtypes based on behavior and genetics, impacting diagnosis and treatment; genetic mutations before or after birth affect subtypes, potentially leading to targeted therapies.
Four Distinct Autism Subtypes Discovered, Unlocking Targeted Treatments
A Princeton University and Simons Foundation study identified four distinct autism subtypes based on behavior and genetics, impacting diagnosis and treatment; genetic mutations before or after birth affect subtypes, potentially leading to targeted therapies.
Progress
36% Bias Score
Panic Attacks vs. Anxiety: Symptoms, Causes, and Treatments
Panic attacks, sudden intense fear episodes with symptoms like chest pain and rapid heartbeat, differ from anxiety; they may stem from brain chemistry, stress response, or underlying health issues, and are treatable through self-care, medication, and CBT.
Panic Attacks vs. Anxiety: Symptoms, Causes, and Treatments
Panic attacks, sudden intense fear episodes with symptoms like chest pain and rapid heartbeat, differ from anxiety; they may stem from brain chemistry, stress response, or underlying health issues, and are treatable through self-care, medication, and CBT.
Progress
24% Bias Score
Statins Linked to 40% Increased Sepsis Survival Rate
A major trial of 12,000 sepsis patients in Israel found that those taking statins had a 39% lower risk of death compared to those not taking statins, highlighting the potential of this medication to significantly reduce sepsis mortality.
Statins Linked to 40% Increased Sepsis Survival Rate
A major trial of 12,000 sepsis patients in Israel found that those taking statins had a 39% lower risk of death compared to those not taking statins, highlighting the potential of this medication to significantly reduce sepsis mortality.
Progress
40% Bias Score
FDA Clears New Blood Test for Alzheimer's Diagnosis
The FDA approved the Lumipulse G Plasma Ratio blood test for Alzheimer's, offering a less invasive and potentially cheaper diagnostic for patients over 55 with cognitive decline; the test achieved 92% accuracy in clinical trials detecting amyloid and tau proteins.
FDA Clears New Blood Test for Alzheimer's Diagnosis
The FDA approved the Lumipulse G Plasma Ratio blood test for Alzheimer's, offering a less invasive and potentially cheaper diagnostic for patients over 55 with cognitive decline; the test achieved 92% accuracy in clinical trials detecting amyloid and tau proteins.
Progress
44% Bias Score
ADHD Medication Prescriptions in the Netherlands Quadruple, Reflecting Increased Diagnosis in Women
A fourfold increase in ADHD medication prescriptions in the Netherlands between 2006 and 2023 reveals that over 300,000 people received prescriptions in 2023, with women now making up over half of those prescribed medication; experts attribute this to improved recognition and diagnosis of ADHD in wo...
ADHD Medication Prescriptions in the Netherlands Quadruple, Reflecting Increased Diagnosis in Women
A fourfold increase in ADHD medication prescriptions in the Netherlands between 2006 and 2023 reveals that over 300,000 people received prescriptions in 2023, with women now making up over half of those prescribed medication; experts attribute this to improved recognition and diagnosis of ADHD in wo...
Progress
36% Bias Score
Ottawa Hospital Joins US$150 Million Bipolar Disorder Research Initiative
The Ottawa Hospital Research Institute received a US$2.3 million grant to join BD², a US$150 million research initiative studying bipolar disorder, aiming to improve diagnosis and treatment by sharing data across 15 institutions and following 4,000 patients for five years.
Ottawa Hospital Joins US$150 Million Bipolar Disorder Research Initiative
The Ottawa Hospital Research Institute received a US$2.3 million grant to join BD², a US$150 million research initiative studying bipolar disorder, aiming to improve diagnosis and treatment by sharing data across 15 institutions and following 4,000 patients for five years.
Progress
44% Bias Score
Annual Strokes in the Netherlands: Immediate Impacts and Misinformation Challenges
Approximately 40,000 people in the Netherlands experience strokes yearly; 80% are ischemic, 20% hemorrhagic; swift medical intervention is crucial due to rapid brain cell loss, with delayed treatment aging the brain by 3.5 years per hour.
Annual Strokes in the Netherlands: Immediate Impacts and Misinformation Challenges
Approximately 40,000 people in the Netherlands experience strokes yearly; 80% are ischemic, 20% hemorrhagic; swift medical intervention is crucial due to rapid brain cell loss, with delayed treatment aging the brain by 3.5 years per hour.
Progress
36% Bias Score
FDA Approves Twice-Yearly Injectable HIV Prevention Treatment
The FDA approved Yeztugo, Gilead's new twice-yearly injectable HIV prevention treatment, on June 18, 2025, showing over 99.9% efficacy in clinical trials involving over 4,000 participants across diverse populations, but concerns remain about its high potential cost.
FDA Approves Twice-Yearly Injectable HIV Prevention Treatment
The FDA approved Yeztugo, Gilead's new twice-yearly injectable HIV prevention treatment, on June 18, 2025, showing over 99.9% efficacy in clinical trials involving over 4,000 participants across diverse populations, but concerns remain about its high potential cost.
Progress
52% Bias Score
NHS Staff Shortages Cause Critical Delays in UK Cancer Care
Due to a shortage of radiologists and oncologists in the UK's NHS, cancer patients face significant delays in diagnosis and treatment, leading to cancer progression and increased mortality risk, as reported by the Royal College of Radiologists (RCR).
NHS Staff Shortages Cause Critical Delays in UK Cancer Care
Due to a shortage of radiologists and oncologists in the UK's NHS, cancer patients face significant delays in diagnosis and treatment, leading to cancer progression and increased mortality risk, as reported by the Royal College of Radiologists (RCR).
Progress
40% Bias Score
Exercise Significantly Reduces Cancer Death and Recurrence Risk
A clinical trial involving 889 colon cancer patients found that a structured exercise program after treatment reduced death risk by 37% and cancer recurrence by 28% compared to a control group, presenting evidence that exercise is as effective as, or better than, some cancer drugs.
Exercise Significantly Reduces Cancer Death and Recurrence Risk
A clinical trial involving 889 colon cancer patients found that a structured exercise program after treatment reduced death risk by 37% and cancer recurrence by 28% compared to a control group, presenting evidence that exercise is as effective as, or better than, some cancer drugs.
Progress
36% Bias Score
Showing 13 to 24 of 139 results